Find and Pitch Jounalists, Get Your Story Covered

Tags: leadership pharma Research & Development research-development biotech

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 5 days ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - about 2 months ago STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 9 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more - 10 months ago STAT+: Up and down the ladder: The latest comings and goings - 10 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - 5 days ago PharmaVoice’s Crystal Ball: The industry’s AI future - 15 days ago 3 closely watched drugs that failed in the clinic - about 1 month ago The big rebrand: Why these 4 biopharmas changed their name this year - about 2 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 3 months ago 2024 PharmaVoice 100s: Trailblazers - 3 months ago Who’s winning in biotech’s tight market? - 4 months ago What 3 layoff stories reveal about pharma’s troubles - 5 months ago What pharma has learned from AI - 6 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 8 months ago Where competition is heating up in pharma - 8 months ago 3 big recent trial flops - 10 months ago The biggest questions hanging over pharma in 2024 - 12 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 10 of our most read articles in 2023 - about 1 year ago 3 standout digital innovations in pharma this year - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago 3 recent FDA adcomm rejections — and why they matter - over 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - 14 days ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	East Asians under-represented in biopharma leadership - 14 days ago STAT+: 3 trends to watch in biotech in 2025 - 28 days ago A key decision on compounding is expected this week - about 1 month ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Eli Lilly seeks to join lawsuit on compounded drugs - 16 days ago Is pharma still fearful of the Inflation Reduction Act? - 5 months ago The biotech news you missed this week - 7 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 8 months ago The biotech updates you need to read today - about 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - about 1 year ago FDA chastens pet companies over antibiotics - about 1 year ago The biotech news you missed from the weekend - about 1 year ago Your Monday morning biotech news roundup - about 1 year ago
6	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Turning the Page - about 1 month ago
7	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
8	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
9	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
10	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	October 2024 Product News - 3 months ago June 2024 Products Column - 7 months ago

Journalists covering BioPharma, Daily, Legal, Pharma